EQ

Equillium, Inc.

2.23 USD

Last updated Sep 5, 11:26 UTC

Yesterday HIGH

$2.25

Yesterday LOW

$2.2

52w HIGH

$3.54

52w LOW

$0.76

EPS

-0.04

PE

-55.75

Next Earnings

Nov 12, 2026

Overview News Government Trades Fundamentals

Equillium, Inc. stock is up 5.19% since 30 days ago. The next earnings date is Nov 12, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 14.29% of the previous 7 September’s closed higher than August.

Benzinga Newsdesk

Tue Jun 2, 2026

Roth Capital Reiterates Buy on Equillium, Maintains $12 Price Target

Roth Capital analyst Adam Walsh reiterates Equillium (NASDAQ:EQ) with a Buy and maintains $12 price target.
Benzinga Newsdesk

Thu May 28, 2026

Leerink Partners Upgrades Equillium to Outperform, Raises Price Target to $6

Leerink Partners analyst Thomas Smith upgrades Equillium (NASDAQ:EQ) from Market Perform to Outperform and raises the price target from $1 to $6.
Benzinga Newsdesk

Thu May 28, 2026

Roth Capital Reiterates Buy on Equillium, Maintains $12 Price Target

Roth Capital analyst Adam Walsh reiterates Equillium (NASDAQ:EQ) with a Buy and maintains $12 price target.
Benzinga Insights

Fri May 15, 2026

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Newsdesk

Wed May 13, 2026

Equillium Q1 EPS $(0.06) Misses $(0.05) Estimate

Equillium (NASDAQ:EQ) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.05) by 20 percent. This is a 75 percent increase over losses of $(0.24) per share from the same
Benzinga Newsdesk

Fri Apr 17, 2026

Roth Capital Reiterates Buy on Equillium, Maintains $12 Price Target

Roth Capital analyst Adam Walsh reiterates Equillium (NASDAQ:EQ) with a Buy and maintains $12 price target.
Benzinga Newsdesk

Thu Apr 16, 2026

B. Riley Securities Initiates Coverage On Equillium with Buy Rating, Announces Price Target of $6

B. Riley Securities analyst William Woods initiates coverage on Equillium (NASDAQ:EQ) with a Buy rating and announces Price Target of $6.
Benzinga Newsdesk

Tue Apr 14, 2026

Raymond James Initiates Coverage On Equillium with Strong Buy Rating, Announces Price Target of $6

Raymond James analyst Martin Auster initiates coverage on Equillium (NASDAQ:EQ) with a Strong Buy rating and announces Price Target of $6.
Benzinga Insights

Mon Apr 13, 2026

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Newsdesk

Tue Apr 7, 2026

Cantor Fitzgerald Initiates Coverage On Equillium with Overweight Rating, Announces Price Target of $10

Cantor Fitzgerald analyst Emma Nealon initiates coverage on Equillium (NASDAQ:EQ) with a Overweight rating and announces Price Target of $10.